CytomX Therapeutics (NASDAQ:CTMX) Cut to Hold at StockNews.com
CytomX Therapeutics (NASDAQ:CTMX – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Monday. Other analysts also recently issued reports about the company. HC Wainwright reissued a “neutral” rating on shares of CytomX Therapeutics in a research note on […]
CytomX Therapeutics (NASDAQ:CTMX – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Monday. Other analysts also recently issued reports about the company. HC Wainwright reissued a “neutral” rating on shares of CytomX Therapeutics in a research note on […]
